Satoshi Osawa, M.D., Ph.D., Professor, Department of Advanced Medical Science for Regional Collaboration, and Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine. Satoshi Osawa received M.D. in 1993 and Ph.D. in 2006 from Hamamatsu University School of Medicine, Japan. In 2012, he was nominated a general manager of Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine. He has focused his scientific interests on treatment of esophageal cancer, intestinal mucosal immunity, and endoscopic diagnosis and therapy for gastrointestinal diseases. He has published several peer-reviewed articles along with research. He is a member of Japanese Society of Internal Medicine, Japanese Society of Gastroenterology, Japan Gastroenterological Endoscopy Society, Physiological Society of Japan, Japanese Society of Medical Oncology, Japanese Gastroenterological Association, Japan Esophageal Society, Japanese Association for Capsule Endoscopy, and Japanese Society of Mucosal Immunology. no comment I am a member of Japanese Society of Internal Medicine, Japanese Society of Gastroenterology, Japan Gastroenterological Endoscopy Society, Physiological Society of Japan, Japanese Society of Medical Oncology, Japanese Gastroenterological Association, Japan Esophageal Society, and Japanese Association for Capsule Endoscopy. Advanced Medical Science for Regional Collaboration: This course, established in April 2025 at Hamamatsu University School of Medicine, is an endowed program supported by Omaezaki City in Shizuoka Prefecture. Shizuoka Prefecture faces a chronic shortage of physicians, with a low doctor-to-population ratio and longstanding disparities in regional healthcare distribution. At the same time, the aging population in the region necessitates enhanced medical services for the elderly. The aim of this course is to develop and disseminate advanced medical technologies in the field of gastrointestinal endoscopy, to promote the use of minimally invasive endoscopic treatments, and to conduct clinical research that supports the digital transformation (DX) of medicine. Through these efforts, we strive to establish an efficient, high-quality healthcare system and to improve medical care in underserved areas.